2019 Archived Content

2019 Speaker List

Marla Abodeely, PhD, Associate Director, Head, Bioassay/Immunoassay Method Development, Shire Pharmaceuticals
Kristin Abrams, Scientist, Amgen, Inc.
Gregory P. Adams, CSO, Sesen Bio
Prasad S. Adusumilli, MD FACS FCCP, Deputy Chief and Associate Attending, Thoracic Surgery; Director, Mesothelioma Program; Head, Solid Tumors Cell Therapy, Cellular Therapeutics Center (CTC), Memorial Sloan-Kettering Cancer Center
Mahiuddin Ahmed, PhD, CSO, Y-mAbs Therapeutics
Juan Carlos Almagro, PhD, Founder and Director, GlobalBio, Inc.
Eric S. Alonzo, PhD, Scientist, Process and Analytical Development, bluebird bio
Zhiqiang An, PhD, Professor, Chemistry, University of Texas Health Science Center at Houston
Marcela Araya, PhD, Principal Scientist, Group Leader, BioMedicine Design, Pfizer
Tara Arvedson, PhD, Director, Oncology Research, Amgen, Inc.
James Baker, Assoc Professor, Chemistry, University College London
Gurusamy Balakrishnan, PhD, Scientist, Bristol-Myers Squibb
Aditya Bardia, Asst Professor, Medicine, Harvard Medical School
Henri Bayle, PhD, Director, Molecular Biology, Research and Development, Bellicum
Roy Baynes, PhD, Senior Vice President, Global Clinical Development & CMO, Merck
Nicola Beaucamp, PhD, Head, Process Research, Roche Innovation Center Munich
Alain Beck, PhD, Senior Director, Biologics CMC and Developability, Pierre Fabre Laboratories
John Bell, Professor, Medicine & Biochemistry, Microbiology & Immunology, Ottawa Hospital Research Institute, University of Ottawa
Itai Benhar, PhD, Professor, Molecular Cell Biology and Biotechnology, Tel-Aviv University
William E. Bentley, PhD, Robert E. Fischell Distinguished Chair, Chemical and Biomolecular Engineering, University of Maryland, College Park
Chantale Bernatchez, PhD, Assistant Professor, Department of Melanoma Medical Oncology - Research, Division of Cancer Medicine, MD Anderson
Carl Uli Bialucha, Director, Oncology Biotherapeutics, Novartis Institutes for Biomedical Research
Roslyn M. Bill, DPhil, Professor, Biotechnology; Associate Dean, Research, Aston University
Philippe Billiald, PharmD, PhD, Professor, Biochemistry, University Paris-Sud & Acticor Biotech
Ruben Boado, Vice President, R&D and Co-Founder, ArmaGen, Inc.
Kristin Boggio, PhD, Senior Scientist, Protein Mass Spectrometry, Pfizer
Björn Boll, PhD, Head, Particle Lab and Higher Order Structure Protein Analytics, Novartis Pharma AG
Bjoern Boll, PhD, Head, Particle Lab and Higher Order Structure Protein Analytics, Novartis
Bettina Bommarius, PhD, Senior Research Scientist, Chemical and Biomolecular Engineering, Georgia Institute of Technology
Gadi Bornstein, PhD, Senior Director, Biologics Discovery, TESARO, Inc.
Martin Jack Borrok, PhD, Scientist II, MedImmune
Adrian Bot, PhD, Vice President, Translational Sciences, Kite Pharma
Rama Boyanapalli, PhD, Associate Director, Bioanalytical and Biomarker Development, Wave Life Sciences
Andrew R.M. Bradbury, MB BS, PhD, CSO, Specifica, Inc.
David Bramhill, PhD, Founder, Bramhill Biological Consulting, LLC
Caroline J. Breitbach, Vice President, R&D Programs and Strategy, Turnstone Biologics
Jo Brewer, PhD, Vice President, Platform Sciences, Adaptimmune
Zachary T. Britton, PhD, Scientist, Antibody Discovery and Protein Engineering, MedImmune, LLC
Julie Brouchon, PhD, Postdoctoral Associate, Weitz Lab, Harvard University
Kristin Brown, PhD, Director, Protein Design and Informatics, GlaxoSmithKline
Johannes Brozy, PhD, Senior Associate Scientist, BiTE® Technology, Amgen Research (Munich) GmbH
Pierre Bruhns, PhD, Professor, Antibodies in Therapy & Pathology, Pasteur Institute
Elizabeth Brunk, PhD, Postdoctoral Research Fellow, Systems Biology Research Group, University of California, San Diego
Dexiu Bu, MD, PhD, Investigator III, Exploratory Immuno-Oncology, Novartis Institute for Biomedical Research
Elizabeth Budde, MD, PhD, Assistant Professor, Department of Hematology & Hematopoietic Cell Transplantation, City of Hope
Richard Buick, PhD, CTO, Fusion Antibodies plc
Nicola Burgess-Brown, PhD, Principal Investigator, Biotechnology, Structural Genomics Consortium, University of Oxford
Noel J. Byrne, MSc, Associate Principal Scientist and Lead, Expression Group, Target Protein Design, Merck Research Laboratories
Iain D. G. Campuzano, Principal Scientist, Discovery Attribute Sciences, Amgen
Qing Chai, PhD, Principal Research Scientist, Protein BioSciences, Eli Lilly & Co.
John Champagne, Senior Applications Scientist\Northeast Regional Manager, Wyatt Technology
Brian Champion, CSO, PsiOxus Therapeutics
Christine P. Chan, PhD, Principal Scientist, Global Manufacturing Science & Technology, Sanofi
Gaurav Chauhan, MS, Associate Principal Scientist, BioProcess Development, Merck & Co., Inc.
Rober Chen, Assoc Professor, Hematology & Hematopietic Cell Transplantation, City of Hope National Medical Center
Daniel Chen, MD, PhD, CMO, IGM Biosciences
Anu Cherukuri, PhD, Associate Director, Immunogenicity Assessment, BioMarin Pharmaceutical
Yongku Cho, PhD, Assistant Professor, Chemical and Biomolecular Engineering, University of Connecticut
Patricia Clark, PhD, John Cardinal O’Hara, C.S.C. Professor, Chemistry & Biochemistry, University of Notre Dame
Adrienne Clements Egan, PhD, Scientific Director, Janssen Biotherapeutics, Janssen
Jennifer R. Cochran, PhD, Shriram Chair of Bioengineering; Professor of Bioengineering, and (by courtesy) Chemical Engineering, Stanford University
Peter Cohen, PhD, Professor, Medicine and Immunology, Mayo
Frank Comer, PhD, Senior Scientist, MedImmune
Christopher Corbeil, PhD, Research Officer, Human Health Therapeutics, National Research Council Canada
Timothy Cripe, Professor and Chief, Division of Hem/Onc/BMT, Nationwide Children's Hospital
Conrad Russell Cruz, PhD, Director, Translational Research Laboratories, Center for Emerging Technologies in Immune Cell Therapy, Children's National Health System
Michael Curran, PhD, Associate Professor, Department of Immunology, MD
Brendan Curti, PhD, Robert W. Franz Chair for Clinical Research, Earle A. Chiles Research Institute, Providence
Katherine Cygnar, Senior Staff Scientist, Genome Engineering Technologies, Regeneron Pharmaceuticals
Tongyun (Tony) Dang, PhD, Senior Scientist, BioTherapeutics Development, Discovery, Product Development, & Supply, Janssen Research & Development
Abhishek Datta, PhD, Director, Antibody Discovery & Engineering, Scholar Rock
Naval G. Daver, MD, Associate Professor, Department of Leukemia, The University of Texas MD Anderson Cancer Center
Claire Davies, Assoc Vice President, Bioanalytics, Sanofi
Charlotte Deane, PhD, Professor of Structural Bioinformatics & Head of Department, Department of Statistics University of Oxford; Head of the Oxford Protein Informatics Group, University of Oxford
Stephanie Dearmey, MD, Pediatrician, Pediatrics, Medical Genetics, Duke University Medical Ctr
Gaël Debauve, PhD, Head, Bioassay Development, Analytical Sciences for Biologics, UCB
Shara Dellatore, PhD, Director, Regulated Immunogenicity and Molecular Biology Bioanalytics, Merck and Co
Mark Dennis, PhD, Fellow, Denali Therapeutics
Vijay Dhawan, PhD, Associate Director, Analytical Development, Sanofi
Iulia Diaconu, PhD, Associate Director, Immunotherapy, Bluebird
Alan Dickson, PhD, Professor, Biotechnology; Director, Centre of Excellence in Biopharmaceuticals (COEBP), University of Manchester
Gundo Diedrich, PhD, Director, Antibody Engineering, MacroGenics
Antonio DiGiandomenico, PhD, Principal Scientist, Microbial Sciences, MedImmune
Nazzareno Dimasi, Assoc Director, R&D, MedImmune
Rakesh Dixit, PhD, Vice President of R&D & Global Head of Translational Sciences-Biologics Safety Assessment, MedImmune
Zhandong Don Zhong, PhD, Associate Director, Specialty Bioanalytics, Teva
Benjamin Doranz, President and CEO, Integral Molecular
Susan Dounce, PhD, Principal SME, Prefilled Syringes, West Pharmaceutical Services
Zhimei Du, PhD, Director, Bioprocess, Merck & Company, Inc.
Franck Duong, PhD, Professor and Principal Investigator, Biochemistry & Molecular Biology, University of British Columbia
David Eavarone, PhD, Associate Principal Scientist, Harbour Biomed
Samuel Ellis, Vice President, Thomson Instrument Company
Peter Ellmark, PhD, Vice President, Discovery, Alligator
Christine E. Engeland, MD, PhD, Head of Laboratory, Virotherapy, National Center for Tumor Diseases
Alan Epstein, Professor, Keck School of Medicine, University of Southern California
Patrik Erlmann, Head, R&D, ViraTherapeutics GmbH
Ugur Eskiocak, PhD, Associate Director, Translational Immunology & Immunopharmacology, Compass Therapeutics
Abbie Esterman, PhD, Senior Scientist, Methods and Analytical Development,
Bristol-Myers Squibb
Tarek Fahmy, PhD, Associate Professor, Biomedical Engineering and Immunobiology, Yale University
Jessy Fan, PhD, Scientist, Amgen
Maria Fardis, PhD, CEO, Iovance
Denise Faustman, PhD, Director of Immunobiology, Massachusetts General Hospital, Associate Professor of Medicine, Harvard
Fortunato Ferrara, PhD, Vice President, Specifica, Inc.
Soldano Ferrone, MD, PhD, Division of Surgical Oncology, Surgery, Massachusetts General Hospital
Deborah Finco, PhD, President, Deborah Finco Consulting LLC, consultant
Simon Fischer, PhD, Head, Cell Line Development, Global Bioprocess & Pharmaceutical Development, Boehringer Ingelheim Pharma GmbH & Co. KG
Anna Fogdell Hahn, PhD, Associate Professor, Clinical Neuroscience, Clinical Neuroimmunology, Karolinska University Hospital, Sweden
Daron Forman, PhD, Principal Scientist, Molecular Discovery Technologies, BMS
Fredrik Frejd, CSO, Affibody AB
Masha Fridkis-Hareli, MSc, PhD, Founder and President, ATR, LLC
Simon Friedensohn, MSc, Research Assistant, Biosystems Science and Engineering, ETH Zurich
Richard Galas, PhD, Senior Scientist, Takeda
Leena Gandhi, MD, PhD, Vice President, Immuno-Oncology Medical Development, Lilly Oncology
Rajkumar Ganesan, PhD, Director, Antibody Engineering, Janssen Biotherapeutics
Sandra Garces, MD, PhD, Senior Medical Advisor for Immunogenicity, GPS Medical and Benefit-Risk Management, Lilly
Narender Gavva, Director, Early Target Discovery, Takeda
Gerald Gellermann, PhD, Senior Fellow, Novartis
Nimish Gera, PhD, Director, Research and Development, Mythic Therapeutics
C. Ronald Geyer, PhD, Professor, Pathology and Lab Medicine, University of Saskatchewan
Sharareh Gholamin, MD, PhD Candidate, Department of Biology and Biological Engineering, California Institute of Technology
Raja Ghosh, PhD, Professor, Chemical Engineering, McMaster University
Theo Giavridis, PhD, Center for Cell Engineering, MSK
David Gilham, PhD, Vice President, Research, Celyad
William Gillette, PhD, Principal Scientist, RAS Reagents Core; Deputy Director, Protein Expression Laboratory, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research (FNL)
Jacob G. Glanville, Co-Founder & CSO, Distributed Bio Inc.
Benjamin Glick, PhD, Professor, Molecular Genetics and Cell Biology, University of Chicago
Sayed Goda, Professor & Senior Scientist, Anti-Doping Lab Qatar, Cairo University
Theresa Goletz, PhD, Global Head, NBE Drug Disposition, EMD serono
María González Pajuelo, CSO, FairJourney Biologics
Ulrich Göpfert, PhD, Principal Scientist, Cell Line & Molecular Development, Roche Innovation Center Munich
Bharathi Govindarajan, PhD, Senior Scientist, Bioassay Development, ImmunoGen, Inc.
Christilyn Graff, PhD, Director, Antibody Discovery and Engineering, Biogen
Paola Grandi, CSO, Cold Genesys
Torbjörn Gräslund, Professor, Protein Science, KTH Royal Institute of Technology
Jonas Heilskov Graversen, Assoc Professor, Molecular Medicine, University of Southern Denmark
Christopher H. Gray, PhD, Staff Scientist & Team Leader, Structural Biology, Drug Discovery Program, CRUK Beatson Institute
James L. Gulley, MD, PhD, FACP, Chief or Genitourinary Malignancies Branch, & Director of Medical Oncology Service, Center for Cancer Research, NCI
Soumi Gupta, PhD, Director, Immunogenicity Assessment, BioMarin Pharmaceutical Inc., Biomarin
Claes Gustafsson, Build Better Biologics with Machine Learning and Synbio, ATUM (formerly DNA2.0)
Markus Haberger, PhD, Senior Scientist, Roche
Graeme Hacking, Medical Director, Amgen, Inc.
William Hallett, PhD, Biologist, OPQ/OBP, CDER, FDA
Jeffrey Harris, Assoc Director, Translational Research, Genmab
Haruki Hasegawa, PhD, Principal Scientist, Biologics – Protein Technology, Amgen, Inc.
Raffit Hassan, MD, Senior Investigator & Chief, Thoracic and GI Malignancies Branch, Center for Cancer Research, National Cancer Institute, NIH
Kathryn Hastie, PhD, Staff Scientist, Immunology and Microbiology, The Scripps Research Institute
Thomas Held, Vice President, ADC Task Force, Daiichi Sankyo
Prof. Dr. Helfrich, WijnandProfessor of Translational Surgical Oncology, Department of Surgery, University Medical Center Groningen
Ronald Herbst, PhD, Vice President and Head, Oncology Research, MedImmune
Guy Hermans, CSO, Isogenica Ltd
Tim Hickling, PhD, Immunogenicity Sciences Lead, Biomedicine Design, Pfizer
Stuart Hicks, Assoc Director, Pipeline R&D, ImmunoGen
Oliver Hill, Vice President, Molecular Biology/Protein Engineering, Drug Discovery, Apogenix AG
MaryJane Hinrichs, Clinical Scientist, Assoc Director, MedImmune
Mitchell Ho, PhD, Chief, Antibody Therapy Section, Laboratory of Molecular Biology, NCI, NIH
F. Stephen Hodi, MD, Professor & Sharon Crowley Martin Chair, Harvard Medical School, Dana-Farber Cancer Institute
Rene Hoet, PhD, Head, Antibody Lead Discovery, Bayer AG
Per Sonne Holm, Head, Virotherapy Research Group, Urology, Technical University Munich
Damian Houde, PhD, Associate Director, Process Analytics, Codiak BioSciences
Jeffrey A. Hubbell, Eugene Belle Professor, Tissue Engineering, Institute for Molecular Engineering, University of Chicago
Michael Hudecek, PhD, Program Leader, Max Eder Research Group‚ CAR T-Cell Engineering, Department of Medicine II, Uni of Wurzburg
Greta Hultqvist, PhD, Associate Senior Lecturer, Pharmaceutical Biosciences, Protein Drug Design,
Duncan Huston-Paterson, Product Manager, Integral Molecular
Catherine Hutchings, PhD, Independent Consultant,
Robert Iannone, Head, R&D, CMO, Immunomedics
Antonio Iglesias, PhD, Expert Scientist, Pharma Research and Early Development, Roche
Gregory C. Ippolito, PhD, Research Assistant Professor, Molecular Biosciences, LIVESTRONG Cancer Institute, The University of Texas at Austin
Juan Jaen, PhD, President, Arcus Bioscience
Anika Jäkel, PhD, Director, Preclinical Pharmacology & Cancer Immunology, Glycotope GmbH
Darshana Jani, MSc, Associate Director, Global Lead Biologics, Clinical Assay Group, Global Product Development, Pfizer, Inc.
Darshana Jani, PhD, Associate Director & Global Lead Biologics, Pfizer Inc, Pfizer
Vibha Jawa, PhD, Director and Lead, Predictive and Clinical Immunogenicity, Merck
Moonsoo M. Jin, PhD, Associate Professor, Molecular Imaging Innovations Institute, Radiology, Weill Cornell Medical College
Matt Johnson, CSO, Avacta Life Sciences
Sujith K. Joseph, PhD, Scientist, Pediatrics Hematology-Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine
Michelle Joubert, Scientist, Analytical Development, Sanofi
Jean-Philippe Julien, PhD, Canada Research Chair in Structural Immunology, The Hospital for Sick Children Research Institute
Meelis Kadaja, PhD, MBA, Director of Business Development, Icosagen Cell Factory
John Kamerud, PhD, Director, Bioanalytical, Pfizer
Denise Karaoglu Hanzatian, PhD, Principal Research Scientist, Biologics Discovery, AbbVie Bioresearch Center, AbbVie
David Karig, PhD, Associate Professor, Systems and Synthetic Biology, Bioengineering, Clemson University
Dennis Karthaus, MSc, IBA Lifesciences
Brian K. Kay, PhD, Professor & Head, Biological Sciences, University of Illinois, Chicago
Alex Kelly, US Business Development Manager, Retrogenix Limited
Ryan Kelly, PhD, Research Scientist, xCella Biosciences
Saad Kenderian, PhD, Assistant Professor, Medicine and Oncology, Mayo
Robert Kernstock, PhD, Senior Group Leader, R&D, Immunochemistry, PPDI
Jennifer Kessler, Senior Development Associate, MacroGenics, Inc.
Bruce Keyt, PhD, CSO, IGM Biosciences
Tarik Khan, PhD, Senior Scientist, Late-Stage Pharmaceutical and Processing Development, F. Hoffmann-La Roche Ltd.
Philip M. Kim, PhD, Associate Professor, The Donnelly Centre for Cellular and Biomolecular Research, Departments of Molecular Genetics and Computer Science, University of Toronto
Yong Sung Kim, PhD, Professor, Molecular Science & Technology, Ajou University
Kei Kishimoto, CSO, Selecta Biosciences
Scott L. Klakamp, PhD, Senior Director & Head, Biophysics, Biologics Development Sciences, Janssen BioTherapeutics
Christian Klein, PhD, Oncology Discovery & Translational Area, Cancer Immunotherapy Discovery, PRED, Roche Innovation Center, Zurich
Hans Klingemann, PhD, Vice President, Research and Development, Nantkwest
Emilee Knowlton, Immunology Sales Specialist, ProImmune Inc.
Luke Koblan, PhD, Scientist, Chemical Biology, Chemistry & Chemical Biology, Harvard University
Sergii Kolodych, CSO, Syndivia
Roland Kontermann, PhD, Professor of Biomedical Engineering, Institute of Cell Biology and Immunology, University of Stuttgart
Serguei Kozlov, Principal Scientist/PM, Team Leader PTO, Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research (NCI)
Daniel Kramer, PhD, Global Scientific Advisor Clinical Immunogenicity, Sanofi, Munich Center
Michael Krogh Jensen, PhD, Senior Researcher & Co-Principal Investigator, Technical University of Denmark, Novo Nordisk Foundation Center for Biosustainability
Andreas Kungl, CEO, Antagonis Biotherapeutics GmbH
Christian Kunz, PhD, Director, MorphoSys AG
Jonathan R. Lai, PhD, Professor, Department of Biochemistry, Albert Einstein College of Medicine
Martine LM Lamfers, Assoc Professor, Neurosurgery, Brain Tumor Center, Erasmus Medical Center
David Lansky, PhD, President, Precision Bioassay, Inc.
Holger Laux, PhD, Fellow, Cell Line Development, Novartis Institutes for BioMedical Research
Sean Lawler, Asst Professor, Managing Director, Harvey Cushing Neurosurgery Laboratories, Brigham and Women's Hospital
Robert J. Lechleider, Senior Vice President, Clinical Research, Seattle Genetics
Sun Bae Lee, Senior Research Scientist, Alteogen
James Legg, PhD, Vice President, Research and Development, Crescendo Biologics
Hans-Georg Lerchen, Chief Scientist, R&D Pharmaceuticals, Bayer AG
Zonghai Li, PhD, CEO and CSO, CARSgen
John Liddell, PhD, Senior Scientific Advisor, National Biologics Manufacturing Centre, Centre for Process Innovation
Thomas Little, PhD, President and CEO, Bioassay Sciences, Thomas A. Little Consulting
David V. Liu, Director, Protein Engineering, Abbvie
Liming Liu, PhD, Senior Principal Scientist, Pharmacokinetics, Pharmacodynamics and Drug Metabolism (PPDM), Merck Research Laboratories
Deryk Loo, PhD, Director, Targeted Therapeutics and Site Operations, MacroGenics, Inc.
James Love, PhD, Chief Operating Officer, Institute for Protein Innovation
Emily Lowe, PhD, Senior Scientist, Analytical Sciences, Kite Pharma, a Gilead Company
Eline T. Luning Prak, MD, PhD, Associate Professor, Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania
Patrick Lupardus, PhD, Senior Scientist and Group Leader, Genentech
Robert Lutz, Principal Consultant, Crescendo Biopharma Consulting
Andrew Lynch, Scientific Consultant, Genedata
Robert Mabry, PhD, Lead, Biologics Research Group, Takeda
Loui Madakamutil, PhD, Vice President, Head of Discovery, Nektar
Sheila G. Magil, PhD, Principal Consultant, BioProcess Technology Consultants, Inc.
Maksim Mamonkin, PhD, Assistant Professor, Center for Cell and Gene Therapy, BCM
John R. Mascola, MD, Director, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, NIH
Yariv S. Mazor, PhD, Senior Scientist, Antibody Discovery & Protein Engineering, MedImmune
Charlotte McDonagh, Vice President, Head of Biotherapeutics, Magenta Therapeutics
Kathleen McGuiness, PhD, Senior Director, Platform Technologies, Unum Therapeutics
Sarah McWhirter, PhD, Director, STING Research, Aduro
Sebastian Meyer, COO, Numab Innovation AG
Shahram Misaghi, PhD, Senior Scientist, Early Stage Cell Culture, Genentech, Inc.
Alexey Misorin, Senior Research Associate, Antibody Discovery, BIOCAD
Arturo Molina, CMO, Sutro Biopharma Inc.
Céline Monnet, Head of Laboratory, Research, LFB Biotechnologies
Hatim Motiwala, PhD, Head, Cell Line Engineering and Bio-Analytical Sciences, Enzene Biosciences Limited
Liviu Movileanu, PhD, Professor, Physics, Syracuse University
Ashley Mullan, Scientist, Development, Analytical Sciences, MedImmune
Smita Nair, Professor, Surgery, Neurosurgery and Pathology, Duke University School of Medicine
Dhaval Nanavati, PhD, Senior Scientist, AbbVie
Brent Nannenga, PhD, Assistant Professor, Chemical Engineering, Arizona State University
Horacio G. Nastri, PhD, Senior Director, Antibody Biotherapeutics, Incyte Corporation
Brad Nelson, PhD, Co-Director, Immunotherapy Program, British Columbia Agency
Jennifer F. Nemeth, PhD, SCPM, Director, Biophysics, Structural Characterization, Biologics Discovery Sciences, Janssen Research & Development
Dario Neri, Professor, Chemistry & Applied Biosciences, Swiss Federal Institute of Technology (ETH Zurich)
Anton Neschadim, CEO, ImmunoBiochem Corporation
Chris Neumann, Principal Scientist, Medicinal Chemistry, Seattle Genetics
Ahuva Nissim, PhD, Professor, Antibody and Therapeutic Engineering, Biochemical Pharmacology, Queen Mary University
Tatiana Novobrantseva, PhD, Co-Founder, Head of Research and Development, Verseau Therapeutics
Mark O’Hara, MD, GI Malignancy Oncologist, University of Pennsylvania
Maureen O'Connor-McCourt, CSO, Forbius
Martin Oft , PhD, Senior Vice President, Preclinical and Clinical R&D, ArmoBio
Shimobi Onuoha , PhD, Head, Protein Engineering, Autolus
Ira H. Pastan, MD, Co-Chief, Laboratory of Molecular Biology; NIH Distinguished Investigator; Head, Molecular Biology Section, NIH
Belinda Pastrana, Chief Executive Officer, Protein Dynamic Solutions
Li Peng, PhD, Vice President, Biotherapeutics Discovery, Palleon Pharmaceuticals
Thomas Pillow, Senior Scientist, Discovery Chemistry, Genentech, Inc.
Renuka Pillutla, PhD, Executive Director, Lead, Bioanalytical Sciences, BMS
Guy Poirier, PhD, Professor, Faculty of Medicine, Scientific Advisor, Proteomics Platform CHU of Quebec, Université Laval
Tony Polverino, PhD, Executive Vice President of Early Development & CSO, Zymeworks Inc.
Francis Poulin, Director, Analytical Development, Sanofi
Daniel Powell, PhD, Associate Professor of Pathology and Laboratory Medicine, Penn
Ken Prentice, Senior Scientist, Biochemistry, Juno Therapeutics
Nuša Pristovšek, PhD, Postdoctoral Researcher, The Novo Nordisk Foundation Center for Biosustainability (CFB), Technical University of Denmark
Jack Ragheb, MD, PhD, Co-Chair, Immunogenicity/Immunosafety Working Group, Senior Medical Fellow for Immunogenicity, Global Patient Safety, Lilly
Ronald T. Raines, PhD, Firmenich Professor of Chemistry, Department of Chemistry, Massachusetts Institute of Technology
G. Jonah Rainey, PhD, CEO, Oriole Biotech, Inc.
Jonah Rainey, PhD, Vice President, Antibody Therapeutics, Gritstone
Romesh Rao, Research Associate, Analytical Sciences, Seattle Genetics
Harun Rashid, Senior Principal Scientist, Molecular Technology, Ambrx
Harun Rashid, PhD, Senior Principal Scientist, Molecular Technology, Ambrx, Inc.
Andreas Raue, PhD, Associate Director, Research, Merrimack
Jeffrey V. Ravetch, MD, PhD, Theresa and Eugene M. Lang Professor, Immunology, Virology, and Microbiology, Rockefeller University
Sai Reddy, PhD, Assistant Professor, Biosystems Science and Engineering, ETH Zurich
Will Redmond, PhD, Associate Member, Laboratory of Cancer Immunotherapy, Director, Immune Monitoring Laboratory, Providence
Susan Richards, PhD, Presidential Scientific Fellow, Translational Medicine Early Development, Sanofi
Paul M. Ridker, MD, MPH, Eugene Braunwald Professor of Medicine, Harvard Medical School
Frank J. Riske, PhD, Senior Consultant, BioProcess Technology Consultants, Inc.
Theo Rispen, PhD, Principle Investigator, Antibody Structure and Function, Sanquin
Mark Rixon, Senior Director, Protein Therapeutics, Alpine Immune Services
Marc-André Robert, PhD, Scientist, Technology Development, BioMarin Pharmaceuticals
David D. Roberts, PhD, Senior Investigator, Head, Biochemical Pathology Section, Laboratory of Pathology, CCR, NCI, NIH
Kevin Roberts, PhD, Senior Scientist and Project Leader, Vhsquared
Gabriel Rocklin, PhD, Assistant Professor, Department of Pharmacology & Center for Synthetic Biology, Northwestern University
Theo Roth, PhD, Department of Microbiology and Immunology, UCLA
Gargi Roy, MSc, Scientist, Antibody Discovery and Protein Engineering, MedImmune, LLC
Marco Ruella, PhD, Clinical Instructor, Associate Director, Dr. June’s Laboratory, Center for Cellular Immunotherapies, Perelman School of Medicine, Penn
Brandon Ruotolo, PhD, Professor, Chemistry, University of Michigan
Stephen J. Russell, CEO, Vyriad Inc.
Charlotte Russell, MD, PhD, CMO, Alligator Bioscience AB
Josiah Ryman T., PhD, Senior Scientist, Predictive and Clinical Immunogenicity, Merck
Clifford William Sachs, PhD, Director, Research and Development, Toxicology, MedImmune
Jochen Salfeld, PhD, Vice President, Global Biologics; Distinguished Research Fellow, AbbVie
Markku Saloheimo, PhD, Senior Principal Scientist, Industrial Biotechnology and Food Solutions, VTT Technical Research Centre of Finland, Ltd.
Lobelia Samavati, MD, Associate Professor of Medicine, Department of Medicine, Center for Molecular Medicine and Genetics, Wayne State University School of Medicine
Hardeep S. Samra, PhD, Senior Director, Head, Regulatory Operations, Orphan Drug Unit, IQVIA
Kristi Sarno, Senior Director Business Development, Pfenex
Barbra Sasu, PhD, CSO, Allogene
Aaron Sato, Chief Scientific Officer, Twist Bioscience
Andreas Schaaf, PhD, Chief Scientific Officer, Greenovation Biotech GmbH
Jonas V. Schaefer, PhD, Lab Head/Investigator II, Novartis Institutes for BioMedical Research (NIBR)
Volker Schellenberger, PhD, CTO, Research & Discovery, Amunix Pharmaceuticals, Inc.
Stefan Scherer, PhD, Senior Vice President, Clinical Development and Deputy CMO, Cellectis
Taylor Schreiber, PhD, CSO, Research & Development, Shattuck Labs
Jane Seagal, PhD, Principal Research Scientist, Global Biologics, AbbVie
Rachana Shah, Investigator, Drug Design and Selection, GlaxoSmithKline
Lu Shan, Scientist, Antibody Discovery & Protein Engineering, MedImmune
Susan Sharfstein, PhD, Professor, Nanobioscience, Nanoscale Science and Engineering, SUNY Polytechnic Institute
Vaneet K. Sharma, PhD, Manager, Analytical Development, Vaccine Development & Manufacturing, International AIDS Vaccine Initiative (IAVI)
Joseph Shiloach, PhD, Director, Biotechnology Core Lab, NIDDK, NIH
Anthony Shock, PhD, Director, Immunology Research, UCB
Sheila K. Singh, MD, PhD FRCS(C), Director or McMaster Surgeon Scientist Program & Professor of Surgery, McMaster University
Anupam Singhal, The Beacon™ Platform for the Rapid Discovery of Rare Antibodies to Difficult Targets, Berkeley Ligts, Inc.
Michael J. Smanski, PhD, Assistant Professor, Biochemistry, Molecular Biology & Biophysics, Biotechnology Institute, University of Minnesota
Christopher Smith, Head of Biologics, US, Genedata
Eric Smith, PhD, Director, Bispecifics, Regeneron Pharmaceuticals
Perceval Sondag, Senior Manager, Statistics, PharmaLex
Paul M. Sondel, MD, PhD, Reed and Carolee Walker Professor of Pediatrics, Human Oncology, and Genetics, and Director of Research, UW Division of Pediatric Hematology, Oncology and BMT, UW Carbone Cancer Center and American Family Children’s Hospital, University of Wisconsin
An Song, PhD, Senior Vice President, Development Sciences, Immune-Onc Therapeutics, Inc.
Christoph Spiess, PhD, Senior Scientist, Antibody Engineering, Genentech
Philipp Spycher, PSI Founder Fellow, Center for Radiopharmaceutical Studies (CRS), Paul Scherrer Institute
Kuldip Sra, PhD, Senior Director, CRISPR Therapeutics
Martin Steegmaier, PhD, Head of Discovery, Large Molecule Research, Roche Pharma Research and Early Development (pRED), Roche Innovation Center Munich
Keri A. Streby, Pediatric Oncologist, Hematology & Oncology, Nationwide Children's Hospital
Robert M. Stroud, PhD, Professor, Biochemistry and Biophysics, Pharmaceutical Chemistry, Macromolecular Structure Group (MSG), University of California, San Francisco (UCSF)
Kay-Gunnar Stubenrauch, PhD, Expert Scientist, Large Molecule Bioanalytical R&D, Roche
Christopher Sucato, Senior Scientist, Charles River
Chaitanya Sudrik, PhD, Postdoctoral Associate, Molecular Engineering, Massachusetts Institute of Technology
Traian Sulea, PhD, Senior Research Officer, Human Health Therapeutics, National Research Council Canada
Sabine Suppmann, PhD, Head, Recombinant Protein Production, Max Planck Institute for Biochemistry
Philip Tagari, PhD, Vice President, Research, Amgen
Yuichiro Takagi, PhD, Associate Professor, Department of Biochemistry and Molecular Biology, Indiana University School of Medicine
Hiroyuki Takeda, PhD, Associate Professor and Principal Investigator, Division of Protea-Drug-Discovery Sciences, Proteo-Science Center, Ehime University
Rastislav Tamaskovic, Head, TC Facility, Biochemistry, University of Zurich
Magdalena Tary-Lehmann, MD, PhD, CSO, Cellular Technology Limited (CTL) & Adjunct Associate Professor of Pathology, Case Western Reserve University (CWRU)
Ali Tavassoli, PhD, Professor, Chemical Biology, University of Southampton
Ronen Tchelet, VP R&D, Dyadic International Inc.,
Grzegorz Terszowski, PhD, Lab Head, PK/PD Bioanalytics Drug Metabolism and Pharmacokinetics Biologics, Novartis
Christopher Thanos, PhD, CEO, Actym Therapeutics
Holger Thie, PhD, Senior Manager, Technology and Innovation, Biologics Development, Boehringer Ingelheim Pharma GmbH & Co. KG
Greg M. Thurber, Asst Professor, Chemical Engineering and Biomedical Engineering, University of Michigan
John Timmer, Vice President, Research, Inhibrx
Sophie Tourdot, PhD, Senior Principal Scientist, Pfizer
Mark Trautwein, PhD, Senior Scientist, Pharmaceuticals R&D, Preclinical Research, Expression Technologies, Bayer AG
Mihriban Tuna, PhD, Vice President, Drug Discovery, F Star
Thomas Tuxen Poulsen, PhD, Principal Scientist, Preclinical Development, Symphogen A/S
Bob Vakamehr, PhD, Chief Development Officer, Fate
Daniel A. Vallera, PhD, Lion Scholar and Professor, Director, Section on Molecular Cancer Therapeutics; Professor of Therapeutic Radiology, University of Minnesota Masonic Cancer Center
Wilfred A. van der Donk, PhD, Richard E. Heckert Endowed Chair in Chemistry, Director of Graduate Studies, and Howard Hughes Medical Institute Investigator, Department of Chemistry, University of Illinois
Anne Verhagen, Director, Protein Biochemistry, CSL Research, CSL Ltd.
Daniela Verthelyi, MD, PhD, Chief, Immunology Lab, Therapeutic Proteins, CDER, FDA
Kurella Vinodh, PhD, Principal Scientist, Protein Engineering, Merrimack Pharmaceuticals
Bjørn Voldborg, MSc, Director, CHO Cell Line Development, The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark
Eric Wakshull, PhD, Principal Scientist, Group Leader, Bioanalytical Sciences, Genentech
Steven Walfish, MBA, Principal Scientific Liaison, USP
Jihong Wang, PhD, Principal Scientist, MedImmune
Lintao Wang, PhD, Associate Director, Analytical and Pharmaceutical Development, ImmunoGen, Inc.
Stacy Ward Ward, PhD, Senior R&D Scientist, Cell Design Studio, MilliporeSigma, MilliporeSigma
Gregory A. Weiss, PhD, Professor, Chemistry, Molecular Biology & Biochemistry, University of California, Irvine
Ron Weiss, PhD, Professor, Biological Engineering, Massachusetts Institute of Technology (MIT)
Duane R. Wesemann, MD, PhD, Principal Investigator, Assistant Professor of Medicine, Harvard Medical School & Associate Physician, Brigham and Women’s Hospital
Tim Whitehead, PhD, Associate Professor, Chemical and Biological Engineering, University of Colorado, Boulder
Sajith Wickramasekara, CEO and Co-Founder, Benchling
Ian Wilkinson, Chief Scientific Officer, Absolute Antibody, Ltd.
Erin Williams, Associate Lab Head of Quality Control, EMD Serono
Pierre Wils, PhD, Head, Biologics Formulation and Process Development, Sanofi
Patrick C. Wilson, PhD, Professor, Medicine & Rheumatology, Knapp Center for Lupus and Immunology Research, Committee on Immunology, University of Chicago
K. Dane Wittrup, PhD, C.P. Dubbs Professor, Chemical Engineering and Biological Engineering; Associate Director, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Liliana Wroblewska, PhD, Principal Scientist, Biomedicine Design, Pfizer, Inc.
Wen Jin Wu, Senior Investigator, OBP, CDER, Food & Drug Administration
Mingjie Xie, CEO, Rapid Novor, Inc.
Ryan Yamagata, US Function Head, CMC Statistical Sciences, Vaccines Technical Research & Development, GSK
Xiaodong Yan, Executive Director, Biortus Biosciences Co., Ltd.
Harry Yang, PhD, Senior Director, Statistical Sciences, Medimmune, LLC
Travis Young, PhD, Vice President, Biologics, CALIBR
Mimi Cho Yung, PhD, Staff Scientist, Biosciences and Biotechnology Division, Physical and Life Sciences Directorate, Lawrence Livermore National Laboratory (LLNL)
Alexandra (Sasha) Zaitsev, Development Associate, Analytical & Pharmaceutical Sciences, ImmunoGen
Alexandra Zakharova, Head, Cell-Based Assay, BIOCAD
Baochun Zhang, PhD, Assistant Professor of Medicine, Department of Medical Oncology, Dana Faber
Shuli Zhang, PhD, Principal Scientist, PPDM Global Bioanalytics, Merck and Co.
Jane Zhao, PhD, Principal Scientist, Immunogen
Qing (Joanna) Zhou, PhD, Product Quality Team Leader, Division of Biotechnology Review and Research I (DBRR I), OBP, CDER, FDA
Li Zhou, PhD, Senior Scientist, Global Biologics, AbbVie
Lisa Zhou, PhD, Senior Scientist, Protein Analytics, AbbVie
Eugene Zhukovsky, PhD, CSO, Biomunex Pharmaceuticals
Stefan Zielonka, PhD, Group Leader & Principal Scientist, Protein Engineering & Antibody Technologies, Discovery Technologies, Global Research and Development, Merck KGaA
Qin Zou, PhD, Group Leader, Analytical Research and Development, Pfizer Inc.